ACTs	Adoptive Cellular Therapies
SASS	Strategic Advances in Sarcoma Science
TME	Tumor Microenvironment
CARs	Chimeric Antigen Receptors
MHC	Major Histocompatibility Complex
TCRs	T Cell Receptors
PC	Peptide-centric
Lete-cel	Letetresgene autoleucel
IL1RAP	Interleukin-1 Receptor Accessory Protein
NK	Natural Killer
MDSCs	Myeloid-Derived Suppressor Cells
TAAs	Tumor-Associated Antigens
TDAs	Tumor Differentiation Antigens
TSAs	Tumor-Specific Antigens
pHLA	Peptide-Human Leukocyte Antigen
NGS	Next-Generation Sequencing
AML	Acute Myeloid Leukemia
TILs	Tumor-Infiltrating Lymphocytes
AI	Artificial Intelligence
DL	Deep Learning
AIDPATH	Artificial Intelligence-driven, Decentralized Production for Advanced Therapies in the Hospital
ECM	Extracellular Matrix
TAMs	Tumor-Associated Macrophages
ARG1	Arginase 1
TGF	Transforming Growth Factor (TGF)-β
IL	Interleukin-10
IDO	Indoleamine 2,3-dioxygenase
TMB	Tumor Mutation Burden
SMRP	Soluble Mesothelin-Related Peptides
MPF	Megakaryocytic Potentiating Factor
ctDNA	Circulating Tumor DNA